Radhakrishnan Srikanth 4
4 · Pulmonx Corp · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Pulmonx CorpLUNG
Radhakrishnan Srikanth
Chief Science &Techn. Officer
Transactions
- Sale
Common Stock
[F1]2026-03-02$1.43/sh−756$1,081→ 180,463 total - Sale
Common Stock
[F2]2026-03-02$1.43/sh−3,068$4,387→ 177,395 total - Sale
Common Stock
[F3]2026-03-02$1.43/sh−2,461$3,519→ 174,934 total - Sale
Common Stock
[F4]2026-03-02$1.43/sh−4,198$6,003→ 170,736 total - Award
Common Stock
[F5]2026-03-02+175,000→ 345,736 total
Footnotes (5)
- [F1]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2022.
- [F2]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
- [F3]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.
- [F4]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025.
- [F5]Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 2, 2026.
Signature
/s/ David Aaron Lehman, Attorney-in-Fact|2026-03-04